- Home
- PHVS vs VERX Comparison
PHVS vs VERX Comparison
Compare PHVS & VERX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHVS | VERX |
|---|---|---|
| Founded | 2015 | 1978 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PHVS | VERX |
|---|---|---|
| Price | $26.36 | $13.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 14 |
| Target Price | ★ $40.70 | $28.29 |
| AVG Volume (30 Days) | 99.0K | ★ 2.4M |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $748,444,000.00 |
| Revenue This Year | N/A | $12.78 |
| Revenue Next Year | N/A | $11.61 |
| P/E Ratio | ★ N/A | $302.25 |
| Revenue Growth | N/A | ★ 12.25 |
| 52 Week Low | $11.51 | $11.87 |
| 52 Week High | $29.80 | $42.44 |
Technical Indicators
Market Signals| Indicator | PHVS | VERX |
|---|---|---|
| Relative Strength Index (RSI) | 46.60 | 40.53 |
| Support Level | $24.05 | $11.91 |
| Resistance Level | $28.43 | $20.44 |
| Average True Range (ATR) | 1.16 | 0.69 |
| MACD | -0.14 | 0.20 |
| Stochastic Oscillator | 32.41 | 46.25 |
Price Performance
Historical ComparisonAbout PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About VERX Vertex Inc.
Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. It provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting, among others. The company derives revenue from software subscriptions.